Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn MoreConnecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MOREEmpowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn moreWorking across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MOREDelivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreClinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn MoreHarness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MOREPharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MOREPrimary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORETrusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MOREOptimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MOREA single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MOREConnected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsOn 27 June 2022, APACMed held the inaugural Value-Based Market Access Symposium. The Symposium leveraged on technical expertise and real-world operating experience from government affairs and market access industry professionals across 15 APAC markets and 40 companies operating in the medical devices and diagnostics sector. IQVIA being a knowledge partner, developed the report which summarizes the insights shared to facilitate innovative, value-based market access, including in pricing, procurement, and reimbursement.
The Value-Based Health Care system (VBHC) is a framework for restructuring health care systems with the overarching goal of maximizing value for patients, where value is defined as health outcomes per unit of cost. The VBHC system can not only lower health care costs with better outcomes in patients, but also make health care by providers more efficient and targeted, thereby enhancing patient satisfaction. With VBHC systems in place, payers will have evidence based metrics for cost control and risk reduction, while industries will be able to align their prices catered more towards patient outcomes. All these factors will in turn benefit society with subsequent reduction in health care spending and prospects of a better overall health scenario. MedTech can significantly contribute across the care continuum that spans prevention, screening, treatment, recovery, and sustainability. Areas of contribution involve device innovation, data analytics, telehealth solutions, and partnership with providers, health assessment technology bodies and payers. The central theme, however, remains universal evidence-based improvement in patient outcomes.
The inaugural APACMed Value-Based Market Access (VBMA) Symposium will revolve around the theme “The Evolving Health Technology Assessment Landscape for Medical Devices and Diagnostics”.